TSLA
Tesla
-- 410.440 NVDA
NVIDIA
-- 144.470 CRNC
Cerence
-- 19.330 RGTI
Rigetti Computing
-- 19.0200 PLTR
Palantir
-- 79.890 
Despite a recent boost in China Resources Double-Crane Pharm...
Despite a recent boost in China Resources Double-Crane Pharmaceutical's stock, its low P/E ratio suggests investors expect limited future growth. The company's forecast growth is lower than the wider market, indicating a potential lack of strong share price rise in the near future.
China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Stock Catapults 26% Though Its Price And Business Still Lag The Market
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment